Optimal regimen for treatment-naive hormone receptor-positive HER-2 negative metastatic breast cancer.

Authors :: Bilgin B
Şendur MA
Hızal M
Akıncı MB
Dede DŞ
Yalçın B
Source :: Future oncology (London, England) [Future Oncol] 2019 Jan; Vol. 15 (2), pp. 105-107. Date of Electronic Publication: 2018 Nov 28.
Publication Year :: 2019

Subjects :: Antineoplastic Combined Chemotherapy Protocols adverse effects
Biomarkers, Tumor
Clinical Trials as Topic
Female
Humans
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Breast Neoplasms drug therapy
Breast Neoplasms metabolism
Receptor, ErbB-2 metabolism
Receptors, Estrogen metabolism
Receptors, Progesterone metabolism

Full Text Access

Tools